145 related articles for article (PubMed ID: 21475076)
1. Prognostic impact of laterality in malignant ovarian germ cell tumors.
Mahdi H; Kumar S; Seward S; Semaan A; Batchu R; Lockhart D; Tamimi H; Munkarah AR
Int J Gynecol Cancer; 2011 Feb; 21(2):257-62. PubMed ID: 21475076
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in survival among patients with germ cell tumors of the ovary--United States.
Bryant CS; Kumar S; Shah JP; Mahdi H; Ali-Fehmi R; Munkarah AR; Deppe G; Morris RT
Gynecol Oncol; 2009 Sep; 114(3):437-41. PubMed ID: 19560191
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
Kumar S; Shah JP; Bryant CS; Imudia AN; Cote ML; Ali-Fehmi R; Malone JM; Morris RT
Gynecol Oncol; 2008 Aug; 110(2):125-32. PubMed ID: 18571705
[TBL] [Abstract][Full Text] [Related]
4. Salvage surgery for chemorefractory ovarian germ cell tumors.
Munkarah A; Gershenson DM; Levenback C; Silva EG; Messing MJ; Morris M; Burke TW
Gynecol Oncol; 1994 Nov; 55(2):217-23. PubMed ID: 7959287
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary.
Mahdi H; Swensen RE; Hanna R; Kumar S; Ali-Fehmi R; Semaan A; Tamimi H; Morris RT; Munkarah AR
Br J Cancer; 2011 Aug; 105(4):493-7. PubMed ID: 21772335
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching.
Chen Y; Ning Y; Zhang Q; Xie Y
Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854
[TBL] [Abstract][Full Text] [Related]
7. The influence of conservative surgical practices for malignant ovarian germ cell tumors.
Chan JK; Tewari KS; Waller S; Cheung MK; Shin JY; Osann K; Kapp DS
J Surg Oncol; 2008 Aug; 98(2):111-6. PubMed ID: 18563734
[TBL] [Abstract][Full Text] [Related]
8. Ovarian germ cell tumors in children. Management, survival and ovarian prognosis. A report of 75 cases.
Vaysse C; Delsol M; Carfagna L; Bouali O; Combelles S; Lemasson F; Le Mandat A; Castex MP; Pasquet M; Moscovici J; Guitard J; Pienkowski C; Rubie H; Galinier P; Vaysse P
J Pediatr Surg; 2010 Jul; 45(7):1484-90. PubMed ID: 20638529
[TBL] [Abstract][Full Text] [Related]
9. Malignant ovarian germ cell tumors: a single-institution experience.
Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in survival in malignant germ cell tumors of the ovary.
Hinchcliff E; Rauh-Hain JA; Clemmer JT; Diver E; Hall T; Stall J; Growdon W; Clark R; Schorge J
Gynecol Oncol; 2016 Mar; 140(3):463-9. PubMed ID: 26773470
[TBL] [Abstract][Full Text] [Related]
11. Incidence and survival rates for female malignant germ cell tumors.
Smith HO; Berwick M; Verschraegen CF; Wiggins C; Lansing L; Muller CY; Qualls CR
Obstet Gynecol; 2006 May; 107(5):1075-85. PubMed ID: 16648414
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors.
Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
Int J Gynecol Cancer; 2019 Mar; 29(3):554-559. PubMed ID: 30700566
[TBL] [Abstract][Full Text] [Related]
13. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of prognostic factors of malignant ovarian tumor after fertility-preserving treatment].
Zeng DY; Shen K; Huang HF; Wu M; Pan LY; Yang JX; Lang JH
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2562-5. PubMed ID: 16321304
[TBL] [Abstract][Full Text] [Related]
16. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
Wang J; Chen R; Li J; Lu X
Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
[TBL] [Abstract][Full Text] [Related]
17. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
[TBL] [Abstract][Full Text] [Related]
18. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
Qin B; Xu W; Li Y
Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
[TBL] [Abstract][Full Text] [Related]
19. Management of early ovarian cancer: germ cell and sex cord-stromal tumors.
Gershenson DM
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S62-72. PubMed ID: 7530680
[TBL] [Abstract][Full Text] [Related]
20. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]